ADG-153

N/A

Report date: 2022/04/15 17:55:52

Base Information

Drug NameADG-153
Drug Alias NameADG153-G1 SAFEbodyADG153ADG153-G1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-Cluster of differentiation 47
TargetsCluster of differentiation 47
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAdagene (Suzhou) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAdagene (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A